A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...

The FDA should have more big news for Vertex only a few weeks later. It expects to announce an approval decision on ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

This guide will walk you through how to get the updated COVID-19 vaccine for free in NYC, even if you are undocumented or ...

Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...

Valneva SE (VALN) said that it has submitted label extension applications to the European Medicines Agency (EMA) and Health Canada to ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

Valneva expects to submit data to the U.S. Food and Drug Administration (FDA) this year to also support potential label extensions in the U.S. IXCHIQ ® is the world’s first and only licensed ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...